课题基金 / 基金详情

Studies on effector molecules of innate immunity responsible for cytotoxicity to tumor cells.

Studies on effector molecules of innate immunity responsible for cytotoxicity to tumor cells.
对负责肿瘤细胞细胞毒性的先天免疫效应分子的研究。
批准号:
10470478
负责人:
NAGASAWA Shigeharu
金额:
$9.34万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B).
财政年份:
1998
资助国家:
日本
项目状态:
已结题
起止时间:
1998 至 2000

项目摘要

项目成果

NAGASAWA Shigeharu的其他基金

相似基金

相关文献

中文摘要
翻译
a .硫脂增强cr3介导的中性粒细胞吞噬作用。硫脂醛是l -选择素的配体,在人中性粒细胞中触发细胞内信号。我们首次发现硫脂能增强cr3介导的人中性粒细胞吞噬作用。我们还观察到,人中性粒细胞中存在未确定的硫fatides受体,并参与增强吞噬作用。b .凋亡细胞和恶性细胞表达的同源补体激活剂。一个;凋亡细胞和原生T细胞都含有一个50 kDa的同源补体激活因子。氨基酸序列分析与延伸因子1α相同。用抗ef -1α.b去除同源补体激活剂活性。我们发现M161Ag在人恶性细胞上表达并诱导同源补体活化。M161Ag与发酵支原体基因产物P48高度同源。结果表明,潜伏感染的发酵分枝杆菌可使人细胞产生M161Ag, M161Ag通过补体激活和细胞因子产生活性,是先天和细胞免疫反应的有效调节剂。
英文摘要
A.Enhancement of CR3-mediated neutrophil phagocytosis by sulfatides.Sulfatides is a ligand for L-selectin and triggers intracellular signals in human neutrophils. We found for the first time the enhancement of CR3-mediated human neutrophil phagocytosis by sulfatides. FcR-mediated phagocytosis was not modified by sulfatides treatment We also observed that unidentified receptor for sulfatides exists on human neutrophils and participates in the enhancement of phagocytosis.B.Homologous complement activators expressed on apoptotic and malignant cells.a ; Apoptotic as well as native T cells were found to contain a homologous complement activator of 50 kDa. Amino acid seqenece analysis was identical to those of elongation factor 1α. The homologous complement activator activity was removed with anti-EF-1α.b. We found a M161Ag, which is expressed on human malignant cells and induces homologous complement activation. cDNA of M161Ag revealed that it is highly homologous to P48, mycoplasma fermentans gene product. It was revealed that latently infected M.fermentans allows human cells to produce M161Ag, which is a potent modulator of innate and cellular immune responses via its complement activating and cytokine-producing activity.
期刊论文(52)
专著(0)
科研奖励(0)
会议论文
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Aoki,H., et al.: "Elongation factor-1a as a homologous complement activator of Jurkat cells."Int.J.Mol.Med.. 6. 87-92 (2000)
Aoki,H., et al.:“作为 Jurkat 细胞同源补体激活剂的延伸因子 1a。”Int.J.Mol.Med.. 6. 87-92 (2000)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Seya,T., et al.: "CD46 (membrane cofactor protein of complement, measles virus receptor) : structural and functional divergence among species (Review)"Inter.J.Mol.Med.. 1. 809-816 (1998)
Seya,T.,等人:“CD46(补体膜辅因子蛋白,麻疹病毒受体):物种之间的结构和功能差异(评论)”Inter.J.Mol.Med.. 1. 809-816 (1998)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Shoki Mikata et al.: "A monomeric human C46-binding protein(C4bp)more efficiently inactivates C3b than natural C4bp;participation of C-terminal domains." Molec.Immunol.35. 537-544 (1998)
Shoki Mikata 等人:“单体人 C46 结合蛋白 (C4bp) 比天然 C4bp 更有效地灭活 C3b;C 末端结构域的参与。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
25
    APOPTOSIS AND COMPLEMENT-STUDIES ON THE MECHANISM OF COMPKEMENT ACTIVATION AND THE BIOLOGICAL SIGNIFICANCE
    • 批准号:
      08457601
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $4.99万
    • 财政年份:
      1996
    • 负责人:
      NAGASAWA Shigeharu
    • 依托单位:
    STUDIES ON THE BIOLOGICAL FUNCTIONS OF THE COMPLEMENT SYSTEM
    • 批准号:
      06454594
    • 项目类别:
      Grant-in-Aid for General Scientific Research (B)
    • 资助金额:
      $4.16万
    • 财政年份:
      1994
    • 负责人:
      NAGASAWA Shigeharu
    • 依托单位:
    Studies on molecular constitution and effector functions of complement system
    • 批准号:
      04454527
    • 项目类别:
      Grant-in-Aid for General Scientific Research (B)
    • 资助金额:
      $4.1万
    • 财政年份:
      1992
    • 负责人:
      NAGASAWA Shigeharu
    • 依托单位:
    Biochemical Studies on Human Inter- trypsin Inhibitor
    • 批准号:
      62580106
    • 项目类别:
      Grant-in-Aid for General Scientific Research (C)
    • 资助金额:
      $0.26万
    • 财政年份:
      1987
    • 负责人:
      NAGASAWA Shigeharu
    • 依托单位:
    国内基金
    海外基金
    酶响应的中性粒细胞外泌体载药体系在眼眶骨缺损修复中的作用及机制研究
    • 批准号:
      82371102
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2023
    • 负责人:
      苏蕴
    • 依托单位: